Yiming Luo
Impact in
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
- Inflammasome and immune disorders 3
- Histone Deacetylase Inhibitors Research 3
- Oncology 10
- CAR-T cell therapy research 3
- Co-authors
- Dean Rao (5 shared papers)Limin Xia (4 shared papers)Zhijuan Lin (8 shared papers)Bing Xu (8 shared papers)Tiantian Wang (2 shared papers)Zhifeng Li (5 shared papers)Junli Lu (3 shared papers)Wenjie Huang (1 shared paper)
- Journals
- Experimental Cell Research (3 papers)Scientific Reports (2 papers)Experimental Hematology and Oncology (2 papers)Cell Death and Disease (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Yiming Luo
34 papers receiving 400 citations
Yiming Luo's Hit Papers
Peers
Comparison fields: 5 of 74
- Immunology 85
- Cancer Research 57
- Hematology 37
- Oncology 87
- Molecular Biology 142
Countries citing papers authored by Yiming Luo
This map shows the geographic impact of Yiming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Luo more than expected).
Fields of papers citing papers by Yiming Luo
This network shows the impact of papers produced by Yiming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Luo. The network helps show where Yiming Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiming Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion Hit paper breakdown → | 2024 | 90 |
| 2 | 2022 | 40 | |
| 3 | 2022 | 31 | |
| 4 | 2020 | 27 | |
| 5 | 2016 | 26 | |
| 6 | 2017 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2015 | 13 | |
| 9 | 2018 | 12 | |
| 10 | 2017 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2018 | 10 | |
| 15 | 2024 | 8 | |
| 16 | 2015 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 1999 | 7 | |
| 20 | 2023 | 5 |
About Yiming Luo
Yiming Luo is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Genetics, having authored 36 papers that have together received 405 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Inflammasome and immune disorders (3 papers), Cancer-related molecular mechanisms research (3 papers), Seed and Plant Biochemistry (3 papers), CAR-T cell therapy research (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Immunology (85 citations), Cancer Research (57 citations), Hematology (37 citations), Oncology (87 citations) and Molecular Biology (142 citations). Yiming Luo has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Dean Rao, Limin Xia, Zhijuan Lin, Bing Xu, Tiantian Wang, Zhifeng Li, Junli Lu, Wenjie Huang, Bixiang Zhang and Xiaoping Chen. Their work appears in journals such as Experimental Cell Research, Scientific Reports, Experimental Hematology and Oncology, Cell Death and Disease and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.